Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma
Article in Frontiers in Immunology (April 2024)
The most recent citing publications are shown below. View all 66 publications that cite this research output on Dimensions.
Toripalimab combined with albumin-paclitaxel plus gemcitabine as first-line treatment for locally advanced or metastatic pancreatic ductal adenocarcinoma: an open-label, phase Ib/II study and investigation of potential biomarkers
Preprint in Research Square (December 2023)
Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE2-dependent IgE inhibition in pancreatic cancer
Article in EBioMedicine (September 2023)